Vertex Pharmaceuticals Incorporated is a pioneering biotechnology company focusing on the development and commercialization of innovative therapies for serious diseases. With a commitment to scientific excellence and patient care, Vertex primarily concentrates on cystic fibrosis and other life-threatening diseases.
Vertex was founded in 1989, marking its journey as a leader in biotechnology. The company is headquartered in Boston, Massachusetts, United States, reflecting its strong presence in the biotech hub of the East Coast.
Vertex's flagship products include groundbreaking treatments for cystic fibrosis, along with research and development in areas such as infectious diseases, cancer, inflammatory and autoimmune diseases, and other rare conditions.
|Dr. Jeffrey Marc Leiden M.D., Ph.D.||Executive Chairman||92.93k||11.49M||1956|
|Dr. Reshma Kewalramani FASN, M.D.||CEO, President & Director||5.22M||N/A||1973|
|Mr. Charles F. Wagner Jr.||Executive VP & CFO||2.06M||N/A||1968|
|Mr. Stuart A. Arbuckle B.Sc.||Executive VP & COO||2.7M||1.26M||1966|
|Dr. David M. Altshuler M.D., Ph.D.||Executive VP of Global Research & Chief Scientific Officer||2.03M||3.09M||1965|
|Ms. Kristen C. Ambrose||Senior VP & Chief Accounting Officer||N/A||N/A||1977|
|Mr. Mike Tirozzi||SVP and Chief Information & Data Officer||N/A||N/A||N/A|
|Susie Lisa||Senior Vice President of Investor Relations||N/A||N/A||N/A|
|Mr. Damian W. Wilmot Esq.||Senior VP, Chief Risk and Compliance Officer||N/A||N/A||1976|
|Mr. Jonathan Biller J.D.||Executive VP & Chief Legal Officer||N/A||N/A||1964|